Skip to content

ARGX

argenx SE

NASDAQ · Healthcare · Biotechnology · NL

$931.38
+3.36%
Ask drillr

Next report

Analyst consensus

Next report date
Feb 25, 2027
EPS estimate
$7.70
Revenue estimate
$3.3B

Latest reported

Last report date
Oct 22, 2026
EPS actual
$7.80
EPS estimate
$7.44
Revenue actual
$2.8B
Revenue estimate
$1.6B

Track record

Trailing twelve quarters

EPS beats (12Q)
6
EPS misses (12Q)
2
EPS in line (12Q)
0
Avg surprise (4Q)
+9.6%
Revenue beats (12Q)
6

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$1.2K
PT range
$861 – $1.4K
Analysts
14
13 Buy1 Hold0 Sell
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Oct 22, 2026$7.44$7.80Beat 4.84%$2.8B
Jul 23, 2026$6.27$7.32Beat 16.75%$2.8B
May 7, 2026$6.00$5.90Miss -1.67%$2.4B
Oct 30, 2025$4.37$5.18Beat 18.54%$948.0M
May 8, 2025$0.98$2.58Beat 163.27%$1.3B
Mar 31, 2025—$2.58—$790.7M
Oct 31, 2024$0.10$1.39Beat 1290.00%$901.9M
Sep 30, 2024—$1.39—$573.2M
May 9, 2024-$0.71-$1.04Miss -46.48%$757.7M
Mar 31, 2024—-$1.04—$401.0M
Oct 31, 2023-$1.48-$1.25Beat 15.54%$468.2M
Sep 30, 2023—-$1.25—$329.8M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 25, 2027